The FDA adverse event database is an important data source to understand safety issues. Using data cleansing, advanced algorithms and co-relating it with multiple data sources in our PharmaFlare data platform one can understand drug interaction combinations and see potential safety issues in the real world that controlled clinical trials cannot easily determine.  However, one can also use similar analytical approaches to understand physicians prescription patterns and behavior. In a case study of the anti-psychotic market, Our technology, analytics & experts evaluated major anti-psychotic drugs looked at various drug interaction combinations and found some revealing insights.